What are the Future Directions for CYP3A4 Inhibitors in Cancer Treatment?
Research is ongoing to develop more selective and potent CYP3A4 inhibitors with fewer side effects. Additionally, personalized medicine approaches are being explored, where genetic profiling of patients can help predict their response to CYP3A4 inhibitors and tailor treatment plans accordingly. The goal is to maximize the therapeutic benefits while minimizing the risks associated with these inhibitors.
